Keynote Lecture: Application of gene therapy for retinal diseases

Retinal gene and stem cell therapies are now being used to treat retinal diseases in a number of clinical trials worldwide. On his keynote lecture on Friday, Professor Robert MacLaren will demonstrate that these therapies have the potential to reverse blindness in cases of complete loss of photoreceptors.